3D Tissue Models 2017: Drug Discovery and Development
3D Tissue Models 2017: Drug Discovery and Development
Monday 28th – Wednesday 30th August 2017, Revere Hotel Boston, Boston, MA.
Alcyomics will be attending the second annual 3D Tissue Models summit which showcases the latest advances in bioengineering and 3D cell culturing with the aim to strengthen the predictability and interpretation of model-based research within preclinical development.
Asif Tulah will be presenting a scientific poster titled: ‘Development of a full-thickness 3D autologous skin equivalent model (Skimune®3D) to determine immunogenicity of therapeutics.’ This will be a first introduction to the autologous 3D skin equivalent model that Alcyomics have developed, with a full launch of this model expected later in the year.
The 3D Tissue Models summit opens a perfect opportunity to see how 3D tissue culture models such as Skimune®3D can aid the drug discovery process through greater accuracy in safety measurements. For more information on this event, visit http://3d-tissuemodels.com/
Poster Session:
Abstract: Development of a full-thickness 3D autologous skin equivalent model (Skimune®3D) to determine immunogenicity of therapeutics
Asif S. Tulah PhD, Shaheda S. Ahmed PhD and Anne M Dickinson PhD
Alcyomics Ltd, Newcastle upon Tyne, United Kingdom
